272 related articles for article (PubMed ID: 24780461)
21. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
[TBL] [Abstract][Full Text] [Related]
22. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
23. Study of diabetic nephropathy in the proteomic era.
Thongboonkerd V
Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
[TBL] [Abstract][Full Text] [Related]
24. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
[TBL] [Abstract][Full Text] [Related]
25. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
26. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
Coughlan MT; Forbes JM
Am J Nephrol; 2011; 34(1):9-17. PubMed ID: 21654162
[TBL] [Abstract][Full Text] [Related]
27. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
28. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
30. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.
Van JA; Scholey JW; Konvalinka A
J Am Soc Nephrol; 2017 Apr; 28(4):1050-1061. PubMed ID: 28159781
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic biomarkers of diabetic nephropathy.
Ito H; Fujita H; Takahashi T
Expert Opin Med Diagn; 2008 Feb; 2(2):161-9. PubMed ID: 23485136
[TBL] [Abstract][Full Text] [Related]
32. New molecular insights in diabetic nephropathy.
Checheriţă IA; Manda G; Hinescu ME; Peride I; Niculae A; Bîlha Ş; Grămăticu A; Voroneanu L; Covic A
Int Urol Nephrol; 2016 Mar; 48(3):373-87. PubMed ID: 26759327
[TBL] [Abstract][Full Text] [Related]
33. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
34. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
35. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
Campion CG; Sanchez-Ferras O; Batchu SN
Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
[TBL] [Abstract][Full Text] [Related]
36. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T
Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862
[TBL] [Abstract][Full Text] [Related]
37. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
Berglund J
Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
[TBL] [Abstract][Full Text] [Related]
38. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
39. Diabetic nephropathy.
Ritz E
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
[TBL] [Abstract][Full Text] [Related]
40. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
